AACR Stories
A postdoctoral fellowship grant from the AACR helped propel Dr. Marco Ruella's research to improve immunotherapy for patients whose disease evaded prior treatment or relapsed.
Learn More in AACR Stories
A postdoctoral fellowship grant from the AACR helped propel Dr. Marco Ruella's research to improve immunotherapy for patients whose disease evaded prior treatment or relapsed.
Learn More in AACR Stories
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreResearch-driven advances in our understanding of the immune system invigorated the field of cancer immunology and established immunotherapy as the fifth pillar of cancer medicine.
Read the ReportCertain diseases and disorders can increase the risk of developing childhood liver cancer, a rare malignancy in children and adolescents. October is Liver Cancer Awareness Month.
Learn MoreIn this episode of the Believe in Progress podcast, our host Mitch Stoller, AACR’s Chief Philanthropic Officer, speaks with former Philadelphia Mayor Michael A. Nutter.
Listen and SubscribeMaking Treatment Decisions: Abigail Johnston shares how she has approached decisions about her cancer care since she was diagnosed with metastatic breast cancer in 2017.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
